Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs ALEMBIC PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN ALEMBIC PHARMA LUPIN/
ALEMBIC PHARMA
 
P/E (TTM) x 40.7 32.2 126.4% View Chart
P/BV x 6.0 4.4 135.5% View Chart
Dividend Yield % 0.2 0.8 30.4%  

Financials

 LUPIN   ALEMBIC PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-23
ALEMBIC PHARMA
Mar-23
LUPIN/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs799792 100.8%   
Low Rs583463 125.8%   
Sales per share (Unadj.) Rs365.8287.6 127.2%  
Earnings per share (Unadj.) Rs9.817.4 56.6%  
Cash flow per share (Unadj.) Rs29.231.4 92.9%  
Dividends per share (Unadj.) Rs4.008.00 50.0%  
Avg Dividend yield %0.61.3 45.4%  
Book value per share (Unadj.) Rs270.7222.3 121.7%  
Shares outstanding (eoy) m454.98196.56 231.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.92.2 86.5%   
Avg P/E ratio x70.236.1 194.6%  
P/CF ratio (eoy) x23.720.0 118.4%  
Price / Book Value ratio x2.62.8 90.4%  
Dividend payout %40.746.0 88.4%   
Avg Mkt Cap Rs m314,381123,402 254.8%   
No. of employees `000NANA-   
Total wages/salary Rs m30,87211,691 264.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m166,41756,526 294.4%  
Other income Rs m1,50930 4,964.1%   
Total revenues Rs m167,92656,557 296.9%   
Gross profit Rs m17,2066,772 254.1%  
Depreciation Rs m8,8072,754 319.8%   
Interest Rs m2,743502 546.7%   
Profit before tax Rs m7,1653,546 202.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,688126 2,131.6%   
Profit after tax Rs m4,4773,420 130.9%  
Gross profit margin %10.312.0 86.3%  
Effective tax rate %37.53.6 1,055.0%   
Net profit margin %2.76.1 44.5%  
BALANCE SHEET DATA
Current assets Rs m124,51329,139 427.3%   
Current liabilities Rs m92,65416,408 564.7%   
Net working cap to sales %19.122.5 85.0%  
Current ratio x1.31.8 75.7%  
Inventory Days Days2610 270.6%  
Debtors Days Days987 1,454.4%  
Net fixed assets Rs m103,49031,498 328.6%   
Share capital Rs m910393 231.5%   
"Free" reserves Rs m122,24643,312 282.2%   
Net worth Rs m123,15643,705 281.8%   
Long term debt Rs m2750-   
Total assets Rs m228,00360,637 376.0%  
Interest coverage x3.68.1 44.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.9 78.3%   
Return on assets %3.26.5 49.0%  
Return on equity %3.67.8 46.5%  
Return on capital %8.09.3 86.7%  
Exports to sales %046.4 0.0%   
Imports to sales %012.1 0.0%   
Exports (fob) Rs mNA26,210 0.0%   
Imports (cif) Rs mNA6,846 0.0%   
Fx inflow Rs m48,05726,210 183.4%   
Fx outflow Rs m21,7526,846 317.7%   
Net fx Rs m26,30619,364 135.8%   
CASH FLOW
From Operations Rs m18,9727,240 262.1%  
From Investments Rs m-12,868-4,476 287.5%  
From Financial Activity Rs m-3,373-2,620 128.7%  
Net Cashflow Rs m2,732144 1,898.7%  

Share Holding

Indian Promoters % 46.8 69.1 67.7%  
Foreign collaborators % 0.3 0.5 54.9%  
Indian inst/Mut Fund % 45.8 19.0 241.0%  
FIIs % 16.1 4.5 356.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.0 30.4 174.3%  
Shareholders   281,542 85,212 330.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Lupin vs ALEMBIC PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Lupin vs ALEMBIC PHARMA Share Price Performance

Period Lupin ALEMBIC PHARMA S&P BSE HEALTHCARE
1-Day 1.23% -0.15% 1.18%
1-Month 0.15% -4.30% -0.75%
1-Year 151.14% 105.43% 61.82%
3-Year CAGR 17.13% 0.89% 18.16%
5-Year CAGR 17.42% 13.56% 19.79%

* Compound Annual Growth Rate

Here are more details on the Lupin share price and the ALEMBIC PHARMA share price.

Moving on to shareholding structures...

The promoters of Lupin hold a 47.0% stake in the company. In case of ALEMBIC PHARMA the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Lupin and the shareholding pattern of ALEMBIC PHARMA.

Finally, a word on dividends...

In the most recent financial year, Lupin paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 40.7%.

ALEMBIC PHARMA paid Rs 8.0, and its dividend payout ratio stood at 46.0%.

You may visit here to review the dividend history of Lupin, and the dividend history of ALEMBIC PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.